SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-20-033605
Filing Date
2020-03-16
Accepted
2020-03-16 06:16:58
Documents
12
Period of Report
2020-03-14
Items
Item 7.01: Regulation FD Disclosure

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2012792d1_8k.htm   iXBRL 8-K 26560
  Complete submission text file 0001104659-20-033605.txt   200423

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA irwd-20200314.xsd EX-101.SCH 3204
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE irwd-20200314_lab.xml EX-101.LAB 34591
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE irwd-20200314_pre.xml EX-101.PRE 22722
6 EXTRACTED XBRL INSTANCE DOCUMENT tm2012792d1_8k_htm.xml XML 3617
Mailing Address 100 SUMMER STREET, SUITE 2300 BOSTON MA 02110
Business Address 100 SUMMER STREET, SUITE 2300 BOSTON MA 02110 617-621-7722
IRONWOOD PHARMACEUTICALS INC (Filer) CIK: 0001446847 (see all company filings)

IRS No.: 043404176 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-34620 | Film No.: 20715164
SIC: 2834 Pharmaceutical Preparations